IPM 036

MTN 030/IPM 041

HPTN 027

IPCAVD 001

VRC 606

Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults (CHARM-03)

Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects

A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04

Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers

HPTN 066